OECD Home › Science and technology › Publications & Documents › Meetings / Conferences / Agendas
Meetings / Conferences / Agendas
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.
This conference, which took place in Paris on 15-17 July 2009, will significantly contribute to accelerating OECD’s current efforts for fostering “green” and innovation-led growth in nanotechnology.
An OECD workshop hosted by Canada will be held on July 23-24, 2009 in Montréal, Québec immediately after the 6th World Congress on Industrial Biotechnology and Bio-processing to discuss progress over the past 5 years in the methodologies used for sustainability assessment of bio-based products.
In recent years, the need to address social and environmental challenges has grown in urgency. Climate change, energy supply and security, agriculture and food security, and water are some of the global challenges that have received increasing attention of the highest political level.
Examples of research collaboration on climate change, food security, energy, and infectious diseases help demonstrate the potential that some key global challenges can be addressed through enhanced international STI co-operation.
English, , 113kb
This workshop will focus on collaborative mechanisms such as IP clearinghouses, patent pools, model/framework agreements, IP exchanges and auctions, and other forms of innovation partnerships. Several initiatives to be presented at the workshop have garnered international attention.
Speech by OECD Deputy Secretary-General Pier Carlo Padoan at the INCOM Workshop on Innovation and Growth Policy in the EU, Prague, 22-23 January 2009
English, , 50kb
Summary and conclusions of a seminar held at the OECD on 16 February 2009.
This workshop will examine ways in which knowledge contributes to innovation, especially in developing countries.
The impact of biotechnologies on medical research is intensifying. Because of new highly performing technologies, we are better able to understand and explore disease and drug mechanisms, which in turn could lead to major changes in the approach of patient care.